Noncanonical Functions of Epigenetic Enzymes and Regulation of Mitochondrial Metabolism

Epigenetic enzymes do not function solely at the chromatin level. Increasing evidence in recent years indicates that DNA methyltransferases, histone acetyltransferases, deacetylases, and demethylases can influence expression of mitochondria-related genes through classical transcriptional regulatory programs, while also departing from the nuclear epigenetic framework to directly enter mitochondria, act on mtDNA or mitochondrial proteins, and participate in respiration, redox homeostasis, and mitochondrial stress adaptation. Precisely because these enzymes simultaneously span both “nuclear program regulation” and “organelle metabolic regulation,” the relationship between epigenetic enzymes and mitochondrial metabolism has shifted from a one-way metabolism-epigenetics coupling model to a bidirectional, multilevel dynamic regulatory network.

Keywords: epigenetic enzymes; noncanonical functions; mitochondrial metabolism; mtDNA; mitochondrial protein acetylation; DNMT1; MOF; LSD1

1 Research Positioning of the Noncanonical Functions of Epigenetic Enzymes

1.1 From chromatin-modifying enzymes to organelle regulatory factors

(1) Extension of the boundary of classical functions

In the traditional sense, epigenetic enzymes are mainly defined as regulatory factors acting on DNA or histone modifications. For example, DNA methyltransferases are responsible for maintenance of DNA methylation, histone acetyltransferases and deacetylases regulate lysine acetylation states, and demethylases participate in remodeling of histone methylation marks. However, the current research trend clearly shows that these enzymes are not restricted to nuclear chromatin, but can also enter the cytoplasm and mitochondria, and may form functional couplings with metabolic enzymes and mitochondrial structural proteins, indicating a substantial outward expansion of their functional boundary.

(2) Basic connotation of noncanonical functions

The so-called noncanonical functions do not negate the epigenetic nature of these enzymes. Rather, they emphasize that once these enzymes depart from the standard context of “nuclear chromatin modification,” they can still directly affect mitochondrial structure, respiratory-chain assembly, metabolic flux, and mitochondrial stress responses through changes in localization, substrate identity, and functional level. Therefore, the core issue in noncanonical function is not “whether the enzyme still modifies histones,” but “whether it begins to directly regulate organelle metabolic behavior.”

1.2 Why mitochondrial metabolism has become a key extended context

(1) Natural coupling between metabolism and epigenetics

Mitochondria are major sources and distribution centers for key metabolites such as acetyl-CoA, 2-oxoglutarate, succinate, fumarate, and NAD+, and these molecules directly determine whether acetylation, deacetylation, and demethylation reactions can proceed efficiently. Mitochondrial metabolism is therefore inherently an important upstream determinant of epigenetic enzyme activity.

(2) Research focus shifts from “metabolism influences epigenetics” to “epigenetic enzymes directly enter mitochondria”

Earlier studies more commonly focused on how mitochondrial metabolites influence nuclear epigenetic modifications. A major recent advance, however, is the discovery that some epigenetic enzymes themselves can translocate into mitochondria and directly act on mtDNA, mitochondrial RNA, or mitochondrial proteins. This moves the framework from “mitochondria influence epigenetics” toward “epigenetic enzymes, in turn, rewrite mitochondrial metabolism.”

2 Major Modes by Which Noncanonical Functions Are Executed

2.1 Mitochondrial nucleic-acid regulatory layer

(1) Mitochondrial extension of DNMT1 function

The most classical identity of DNMT1 is as a maintenance DNA methyltransferase for nuclear DNA. However, studies have proposed that a mitochondria-related isoform of DNMT1 can localize to mitochondria and bind the mtDNA control region. More recent work has further extended DNMT1 function from DNA methylation alone to RNA binding and RNA modification, suggesting that DNMT1 may participate not only in mtDNA-related regulation, but also in mitochondrial function through modulation of the stability and modification state of metabolism-related RNA transcripts.

(2) Research boundaries of mitochondrial nucleic-acid regulation

It should be noted that the scope, abundance, and functional significance of mitochondrial epigenetic modification remain under discussion, and not all studies support a regulatory pattern as clear as that seen for nuclear DNA modification. Nonetheless, the concept that “epigenetic enzymes can enter mitochondria and participate in mitochondrial nucleic-acid regulation” has itself moved from hypothesis into the stage of mechanistic investigation.

2.2 Post-translational modification layer of mitochondrial proteins

(1) MOF shifts from a nuclear HAT to a mitochondrial acetyltransferase

MOF has long been regarded as a histone acetyltransferase catalyzing H4K16 acetylation. Recent studies, however, suggest that MOF is not restricted to the nucleus. It can enter mitochondria and directly acetylate mitochondrial proteins, including components related to respiratory-complex assembly and ATP synthesis. In other words, the noncanonical function of MOF has been substantially extended from “regulating nuclear gene expression” to “directly rewriting the functional state of mitochondrial proteins.”

(2) HDAC6 shifts from a cytoplasmic deacetylase to a mitochondrial structural regulator

HDAC6 is not usually regarded as a typical mitochondrial enzyme, yet recent studies indicate that its functional extension reaches deeply into the mitochondrial layer. Inhibition or knockdown of HDAC6 can alter mitochondrial cristae structure, affect mtDNA stability, and couple with TCA-cycle-related enzymes. This indicates that HDAC6 is no longer merely a deacetylase of microtubules or cytoplasmic proteins, but instead directly participates in regulation of mitochondrial metabolic enzymes and membrane structural stability.

Table 1. Major modes by which noncanonical functions of epigenetic enzymes are executed

Functional layer	Representative enzyme	Noncanonical target	Major effect on mitochondrial metabolism
Mitochondrial nucleic-acid layer	DNMT1	mtDNA, mtRNA/metabolism-related RNA transcripts	Influences mitochondrial transcription and metabolic output
Mitochondrial protein-modification layer	MOF	Mitochondrial proteins such as COX17 and ATP5B	Alters respiratory-chain assembly and ATP-synthesis efficiency
Mitochondrial structural layer	HDAC6	Mitochondrial cristae structure, FH-related complexes	Influences metabolic flux and mtDNA stability
Metabolic-program layer	LSD1	PGC-1alpha/OXPHOS-related transcriptional networks	Regulates mitochondrial biogenesis and oxidative metabolism
Stress-adaptation layer	HDAC family/chromatin regulators	UPRmt-related gene programs	Alters the threshold of mitochondrial stress responses

2.3 Metabolic-program and mitochondrial-biogenesis layer

(1) LSD1 is no longer merely an H3K4 demethylase

The most classical definition of LSD1 is as a demethylase associated with H3K4/H3K9-related marks. However, its function has clearly expanded beyond “modifying a single histone site.” Both earlier and recent studies suggest that LSD1 can regulate PGC-1alpha, oxidative-phosphorylation-related genes, and mitochondrial biogenesis programs, thereby directly influencing oxidative metabolic capacity in adipose and other metabolic tissues. In other words, the noncanonical significance of LSD1 lies not merely in changing chromatin accessibility, but in resetting whether the cell favors energy storage, thermogenesis, or enhanced mitochondrial respiration.

(2) LSD1 also possesses metabolic-sensing properties

LSD1 depends on FAD for its activity, which naturally couples it to cellular redox state and mitochondrial metabolism. For this reason, LSD1 is often considered an important node linking nutritional status, electron-acceptor availability, and mitochondrial transcriptional programs. The key to its noncanonical function is not entry into mitochondria, but rather continuous translation of mitochondrial metabolic state into nuclear oxidative-metabolic programs.

2.4 Mitochondrial stress and retrograde-signaling layer

(1) Epigenetic enzymes participate in UPRmt-related programs

Mitochondrial damage is not handled exclusively within mitochondria, but also triggers retrograde signals to the nucleus, inducing expression of a series of chaperones, proteases, and metabolic adaptation programs. Relevant studies indicate that HDAC family members and related chromatin regulators participate in transcriptional remodeling associated with the mitochondrial unfolded protein response, suggesting that the significance of epigenetic enzymes at this level lies not only in modifying nuclear chromatin, but also in acting as adapters of mitochondrial stress to reorganize whole-cell metabolic status.

(2) Cross-compartment coordination is the key to noncanonical function

When epigenetic enzymes act simultaneously on both nucleus and mitochondria, their truly important role is not any single local reaction, but rather cross-compartment coordination: on the one hand, directly modifying mitochondrial components, and on the other, adjusting expression of nuclear-encoded mitochondrial genes, thereby achieving bidirectional synchronization of the metabolic network.

3 Core Output Layers Through Which Epigenetic Enzymes Influence Mitochondrial Metabolism

3.1 Oxidative phosphorylation and respiratory-chain layer

(1) Respiratory-chain assembly layer

One of the most direct outcomes of noncanonical epigenetic-enzyme function is alteration of respiratory-chain assembly efficiency. MOF-dependent acetylation of proteins related to respiratory-chain assembly and ATP-synthesis modules indicates that such enzymes can act directly on mitochondrial protein assembly and energy conversion without passing through a nuclear transcriptional layer, thereby influencing electron-transport-chain efficiency and ATP-production capacity.

(2) Respiratory efficiency and energy-output layer

When the acetylation or deacetylation status of mitochondrial proteins is altered, cells exhibit systematic reprogramming in respiratory intensity, ATP level, and strategies of metabolic substrate utilization. Thus, the noncanonical function of epigenetic enzymes is not a local modification event, but may determine whether the cell maintains high oxidative phosphorylation, shifts toward compensatory glycolysis, or enters an energy-crisis state.

3.2 TCA-cycle and redox layer

(1) Regulation of key TCA nodes

The interaction between HDAC6 and fumarate hydratase suggests that noncanonical functions of epigenetic enzymes can extend deeply into TCA-cycle nodes. Because intermediates such as fumarate and succinate are not only metabolites but also important signals in redox and epigenetic regulation, such control can simultaneously affect mitochondrial flux and the global epigenetic environment of the cell.

(2) Oxidative-stress and metabolic-stress layer

DNMT1 abnormality, HDAC6 inhibition, and certain forms of mitochondrial hyperacetylation are all associated with increased oxidative stress and impaired mitochondrial function. This indicates that the effects of noncanonical epigenetic-enzyme function on mitochondrial metabolism usually do not take the form of a change in single-substrate flux alone, but instead rewrite redox homeostasis, membrane integrity, and the threshold for metabolic stress together.

3.3 Mitochondrial quality-control layer

(1) Cristae and membrane-structure homeostasis

Mitochondrial metabolism is determined not only by enzymes, but also by cristae architecture, membrane contact sites, and nucleoid stability. The importance of HDAC6 research lies precisely in showing that noncanonical functions of epigenetic enzymes can directly affect mitochondrial ultrastructure, and that ultrastructural changes can in turn influence respiratory-chain arrangement, electron-transfer efficiency, and mtDNA release.

(2) Mitophagy and stress adaptation

When imbalance in mitochondrial metabolism persists, cells must rely on quality control and mitophagy to maintain homeostasis. Studies on HDAC-related pathways as well as comparative studies of the SIRT axis indicate that deacetylation networks are tightly linked to mitochondrial quality control, suggesting that the extended functions of epigenetic enzymes can also encompass recognition, isolation, and metabolic adaptation of damaged mitochondria.

Table 2. Core output layers through which epigenetic enzymes affect mitochondrial metabolism

Output layer	Major affected process	Representative enzyme	Typical consequence
Respiratory-chain layer	Complex assembly, ATP synthesis	MOF	Changes in respiratory efficiency and energy output
TCA layer	Activity of metabolic nodes such as FH	HDAC6	Changes in intermediate-metabolite profiles and redox state
Mitochondrial gene-expression layer	mtDNA/mtRNA-related regulation	DNMT1	Reorganization of mitochondrial transcription and metabolic adaptation
Biogenesis layer	PGC-1alpha, OXPHOS programs	LSD1	Changes in mitochondrial abundance and oxidative-metabolic capacity
Stress-adaptation layer	UPRmt, quality control, autophagy	HDAC family/related regulators	Altered tolerance threshold for mitochondrial injury

4 Significance in Disease and Research Contexts

4.1 Neurodegenerative and metabolic disease contexts

One particularly important implication of DNMT1-related research is that it explicitly links “epigenetic-enzyme abnormality-mitochondrial dysfunction-neurodegenerative phenotype.” Related work suggests that DNMT1 abnormalities can simultaneously lead to imbalanced nucleic-acid modification, altered metabolic transcripts, increased oxidative stress, and mitochondrial dysfunction, thereby helping explain certain neurodegenerative pathologies.

4.2 Cardiovascular and stress-injury contexts

Research on mitochondrial MOF suggests that once epigenetic enzymes enter mitochondria, they can directly rewrite the terminal machinery of energy metabolism, leading to insufficient ATP production and a state of mitochondrial hyperacetylation. This implies that in organs with high energy demand, the noncanonical functions of epigenetic enzymes are unlikely to be marginal phenomena, but may instead represent core amplification layers in pathological progression.

4.3 Tumor and metabolic-plasticity contexts

Tumor cells are highly dependent on mitochondrial metabolic plasticity, and the noncanonical functions of epigenetic enzymes are therefore of particular significance in cancer. The effects of HDAC6 on fumarate hydratase and cristae structure, and the regulation of oxidative-metabolic programs by LSD1, both indicate that tumor-associated epigenetic enzymes do not merely rewrite chromatin, but directly participate in metabolic adaptation and mitochondrial remodeling.

5 Related Research Products

The following products are intended mainly for mechanistic studies and functional validation rather than for clinical use.

Table 3. Product table related to noncanonical functions of epigenetic enzymes and mitochondrial-metabolism regulation

Name	CAS No.	Experimental stage	Key use	Use notes
5-Azacytidine	320-67-2	DNA methylation layer	Classical DNMT inhibitor used to evaluate the effects of altered DNA methylation on mitochondrial transcription and metabolism	Suitable for nuclear-mitochondrial coupling studies
Decitabine	2353-33-5	DNA methylation layer	Commonly used to inhibit maintenance DNA methylation and analyze DNMT1-related metabolic phenotypes	Suitable for comparison of short-term and long-term treatment
Zebularine	3690-10-6	DNA methylation layer	Used for relatively mild inhibition of DNA methylation and observation of changes in mitochondrial response threshold	Suitable for stable-treatment models
RG108	48208-26-0	DNMT functional-validation layer	Non-nucleoside DNMT inhibitor used to validate DNMT-dependent metabolic reprogramming	Suitable for use with demethylation readouts
Procainamide	51-06-9	DNA methylation comparison layer	Used as an earlier methylation-inhibition tool for low-intensity intervention controls	More suitable for supplementary mechanistic validation
Trichostatin A	58880-19-6	Broad-spectrum HDAC layer	Used to analyze mitochondrial protein acetylation and metabolic changes after deacetylation inhibition	Suitable for construction of hyperacetylation backgrounds
Vorinostat	149647-78-9	Broad-spectrum HDAC layer	Used to study coupling between histone/non-histone deacetylation and mitochondrial metabolism	Suitable for phenotype-level validation
Panobinostat	404950-80-7	Broad-spectrum HDAC layer	Used for potent HDAC inhibition to observe changes in mitochondrial metabolism and stress output	Suitable for tumor-metabolism models
Entinostat	209783-80-2	Class I HDAC layer	Used to distinguish nuclear transcriptional effects from mitochondrial metabolic outputs	Suitable for comparison with broad-spectrum HDAC inhibitors
Tubastatin A HCl	1310693-92-5	HDAC6-specific layer	Used to validate the effects of HDAC6 on mitochondrial cristae, FH, and mtDNA stability	Suitable for noncanonical-function studies
PCI-34051	950762-95-5	HDAC8 comparison layer	Used to distinguish HDAC6-specific effects from those of other deacetylases	Suitable for intrafamily comparison experiments
Sirtinol	410536-97-9	Sirtuin layer	Used to analyze the relationship between the NAD+-dependent deacetylation axis and mitochondrial metabolism	Suitable for use with NAD+ precursors
EX-527	49843-98-3	SIRT1 layer	Used to study the SIRT1-dependent component of nuclear-mitochondrial transcriptional coupling	Suitable for analysis of PGC-1alpha-related programs
Nicotinamide	98-92-0	Sirtuin comparison layer	Commonly used as a background inhibitor for NAD+-related deacetylases	Suitable for metabolic-rescue experiments
C646	328968-36-1	p300/CBP acetylation layer	Used to analyze the effects of altered acetyltransferase activity on mitochondrial gene programs	More relevant to the nuclear-mitochondrial coupling layer
Anacardic acid	16611-84-0	HAT inhibition layer	Used for broad interference with acetyltransferase-related processes	Suitable for initial acetylation-mechanism screening
Garcinol	78824-30-3	HAT inhibition layer	Used to compare metabolic reprogramming under different HAT-inhibition backgrounds	Suitable for supplementary validation
GSK-J4 HCl	1797983-09-5	KDM6 layer	Used to analyze the relationship between H3K27 demethylation and mitochondrial metabolism/stress	Suitable for stress and inflammation models
IOX1	5852-78-8	JmjC demethylation layer	Broad-spectrum 2-oxoglutarate-dependent oxygenase inhibitor used to validate demethylation and metabolite dependence	Suitable for alpha-KG competition studies
DMOG	89464-63-1	2-Oxoglutarate competition layer	Used to mimic inhibition of 2-oxoglutarate-dependent enzymes and analyze coupling between demethylation and metabolism	Suitable for hypoxia/pseudohypoxia backgrounds
beta-Nicotinamide mononucleotide	1094-61-7	NAD+ supply layer	Used to increase NAD+ availability and analyze responses of the sirtuin-mitochondrial axis	Suitable for metabolic-rescue design
NAD+	53-84-9	Cofactor layer	Used to study deacetylation-dependent regulation of energy metabolism	More suitable for in vitro enzyme-activity and supplementation experiments
2-Oxoglutarate	328-50-7	Metabolic cofactor layer	Key cofactor for JmjC demethylases and TET-related enzymes, used to analyze metabolism-demethylation coupling	Suitable for metabolic-supplementation experiments
Succinate	110-15-6	TCA signaling layer	Used to construct backgrounds of inhibited 2-oxoglutarate-dependent enzymes and metabolic reprogramming	Suitable for pseudohypoxia and epigenetic-regulation studies
Fumarate	110-17-8	TCA signaling layer	Used to analyze the effects of abnormal FH-related metabolic nodes on epigenetic state and mitochondrial function	Suitable for FH/HDAC6-related models
Sodium acetate	127-09-3	Acetyl-donor layer	Used to increase acetyl-CoA-related input and analyze the relationship between acetylation and mitochondrial function	Suitable for acetylation-supplementation experiments
Sodium butyrate	156-54-7	HDAC inhibition/metabolic layer	Possesses both metabolite and HDAC-inhibitory characteristics, used to analyze the effects of short-chain fatty acids on mitochondrial regulation	Suitable for studies with combined metabolic and epigenetic inputs
2-Deoxy-D-glucose	154-17-6	Glycolysis-intervention layer	Used to force cells toward greater reliance on mitochondria, thereby amplifying noncanonical epigenetic effects	Suitable for metabolic-stress models
Oligomycin A	579-13-5	OXPHOS layer	ATP synthase inhibitor used to validate the influence of epigenetic-enzyme regulation on respiratory-chain output	Suitable for Seahorse and related functional assays
FCCP	370-86-5	Mitochondrial uncoupling layer	Used to assess maximal respiration and reserve respiratory capacity	Suitable for mitochondrial functional analysis
Rotenone	83-79-4	Complex I layer	Used to construct respiratory-chain inhibition backgrounds and observe responses of epigenetic enzymes	Suitable for complex-specific studies
Etomoxir	124083-20-1	Fatty-acid-oxidation layer	CPT1 inhibitor used to analyze the effects of epigenetic enzymes on substrate preference	Suitable for lipid-metabolism-dependent models
UK5099	56396-35-1	Pyruvate-input layer	Mitochondrial pyruvate carrier inhibitor used to validate the contribution of glucose-derived input into mitochondria	Suitable for metabolic-flux allocation studies
MitoTEMPO	1334850-99-5	Mitochondrial ROS layer	Mitochondria-targeted antioxidant used to analyze the role of ROS in noncanonical epigenetic functions	Suitable for oxidative-stress validation
CPI-613 (Devimistat)	95809-78-2	TCA intervention layer	Used to interfere with mitochondrial metabolic-enzyme complexes and amplify metabolic-adaptation phenotypes	Suitable for tumor mitochondrial models
Resveratrol	501-36-0	Sirtuin/metabolic-regulation layer	Commonly used in studies of the SIRT axis and mitochondrial biogenesis	Suitable for paired design with NAD+ supplementation

Table 4. Product table related to epigenetic enzymes and mitochondrial-metabolism regulation

Catalog No.	Name	Grade and Purity	Corresponding mechanistic layer	Research direction/intended use
Ab100220	Recombinant Dnmt1 Antibody	recombinant, ExactAb™, validated, see COA	Mitochondrial nucleic-acid regulatory layer	Used to detect DNMT1 expression, localization changes, and nuclear-mitochondrial coupling
rp217144	Recombinant Human DNMT1 Protein	carrier-free, His-tagged, ≥85%(SDS-PAGE), see COA	Mitochondrial nucleic-acid regulatory layer	Used for in vitro enzyme-activity assays, binding studies, and validation of noncanonical DNMT1 functions
rp329943	Recombinant Mouse DNMT1 Protein	≥90%(SDS-PAGE)	Mitochondrial nucleic-acid regulatory layer	Used in studies of DNMT1-related mitochondrial regulatory mechanisms in mouse systems
EJ1513497	Human DNA Methyltransferase 1 (DNMT1) ELISA Kit	BioReagent	Mitochondrial nucleic-acid regulatory layer	Used for quantitative analysis of DNMT1 levels in human samples and detection related to metabolic reprogramming
EJ1512501	Mouse DNA Methyltransferase 1 (DNMT1) ELISA Kit	BioReagent	Mitochondrial nucleic-acid regulatory layer	Used to analyze the association between DNMT1 and mitochondrial functional changes in mouse models
Ab100246	Recombinant Dnmt3a Antibody	recombinant, ExactAb™, validated, see COA	Extended DNA methylation layer	Used to compare functional division between DNMT1 and DNMT3A in metabolic-program rewriting
rp218433	Recombinant Human DNMT3A Protein	carrier-free, His-tagged, ≥95%(SDS-PAGE), see COA	Extended DNA methylation layer	Used in studies of coupling between de novo methylation and expression of mitochondria-related genes
EJ1513496	Human DNA Methyltransferase 3A (DNMT3A) ELISA Kit	BioReagent	Extended DNA methylation layer	Used for quantitative analysis of DNMT3A expression and comparative analysis of DNA-methylation backgrounds
Ab111791	Recombinant KAT8/MYST1/MOF Antibody	ExactAb™, Validated, recombinant, 2.0 mg/mL	Mitochondrial protein-acetylation layer	Used to detect MOF expression, localization, and its relationship to mitochondrial acetylation output
B286988	BRD 9757	≥98%(HPLC)	Mitochondrial structural-regulation layer	Used to analyze the effects of HDAC6 on mitochondrial cristae structure, protein acetylation, and metabolic adaptation
D127578	Droxinostat	Moligand™, ≥96%	Deacetylation-regulation layer	Used to compare synergistic effects of HDAC6 and other HDAC members on mitochondrial metabolic output
H420452	HDAC6 inhibitor	Moligand™, 10 mM in DMSO	Mitochondrial structural-regulation layer	Used for rapid validation of HDAC6-dependent changes in mitochondrial morphology and function
Ab107079	Recombinant HDAC6 Antibody	recombinant, ExactAb™, knockdown validated, validated, high performance, see COA	Mitochondrial structural-regulation layer	Used to detect HDAC6 expression, subcellular localization, and mitochondrial phenotypes after knockdown
T288021	Tubacin	≥96%(HPLC)	Mitochondrial structural-regulation layer	Commonly used to validate regulation by HDAC6 of FH, cristae structure, and mtDNA stability
EJ1514573	Human Histone Deacetylase 6 (HDAC6) ELISA Kit	BioReagent	Mitochondrial structural-regulation layer	Used for quantitative analysis of HDAC6 levels in human cells or tissues
Ab325941	Recombinant SIRT3 Antibody	knockdown validated	Mitochondrial deacetylation layer	Used to detect SIRT3 expression and its relationship to mitochondrial respiration and ROS homeostasis
EJ1513919	Human Sirtuin3 (SIRT3) ELISA Kit	BioReagent	Mitochondrial deacetylation layer	Used for quantitative analysis of SIRT3 in human samples and correlation with mitochondrial metabolic phenotypes
EJ1512100	Rat Sirtuin 3 (SIRT3) ELISA Kit	BioReagent	Mitochondrial deacetylation layer	Used in rat models to study the relationship of SIRT3 with energy metabolism and oxidative stress
EJ1512841	Mouse Sirtuin 3 (SIRT3) ELISA Kit	BioReagent	Mitochondrial deacetylation layer	Used for monitoring dynamic changes in SIRT3 in mouse models
Ab127693	SIRT5 Mouse mAb	see COA	Mitochondrial acyl-modification layer	Used to detect SIRT5 expression and study mechanisms related to desuccinylation and demalonylation
EJ1513916	Human Sirtuin 5 (SIRT5) ELISA Kit	BioReagent	Mitochondrial acyl-modification layer	Used for SIRT5 level detection and evaluation of mitochondrial acyl-modification status
Ab111906	Recombinant KDM1/LSD1 Antibody	recombinant, ExactAb™, validated, see COA	Metabolic-program rewriting layer	Used to detect LSD1 expression and study its regulation of PGC-1alpha/OXPHOS programs
S275384	SP-2509	≥98%	Metabolic-program rewriting layer	Used to inhibit LSD1 activity and analyze its effects on mitochondrial biogenesis and oxidative metabolism
EJ1514963	Human Lysine-specific Histone Demethylase 1A (LSD1) ELISA Kit	BioReagent	Metabolic-program rewriting layer	Used for quantitative analysis of LSD1 and its association with metabolic reprogramming
EJ1514544	Human Transcription Factor A, Mitochondrial (TFAM) ELISA Kit	BioReagent	Mitochondrial nucleic-acid homeostasis layer	Used to detect TFAM levels and evaluate mtDNA packaging and transcriptional homeostasis
EJ1512213	Rat Transcription Factor A, Mitochondrial (TFAM) ELISA Kit	BioReagent	Mitochondrial nucleic-acid homeostasis layer	Used in rat models to study TFAM changes and mitochondrial replication/transcription
EJ1513025	Mouse Transcription Factor A, Mitochondrial (TFAM) ELISA Kit	BioReagent	Mitochondrial nucleic-acid homeostasis layer	Used to monitor TFAM levels in mouse models
EJ1513495	Human DNA Polymerase Subunit Gamma 1(POLg1) ELISA Kit	BioReagent	mtDNA replication layer	Used to evaluate POLgamma1 levels and changes related to mitochondrial DNA replication stress
Ab327028	Recombinant ATP5B Antibody	knockdown validated	Respiratory-chain and ATP-synthesis layer	Used to detect ATP5B expression and validate the effects of MOF/acetylation on ATP-synthesis modules

The noncanonical functions of epigenetic enzymes are redefining this class of molecules from “nuclear chromatin-modifying enzymes” into “cross-compartment metabolic regulators.” These enzymes can influence mitochondria indirectly through classical transcriptional regulation, but can also directly rewrite respiration, the TCA cycle, redox homeostasis, and quality-control programs by entering mitochondria, modifying mitochondrial proteins, or regulating mitochondrial nucleic acids. Because this functional expansion simultaneously covers the dual interface of nucleus and mitochondria, the relationship between epigenetic enzymes and mitochondrial metabolism is no longer adequately explained by a simple one-way causal model, but should instead be understood as a bidirectionally coupled, dynamically restructured regulatory network.

For more related articles, please see below:

[1] Transposase-Based Epigenomic Sequencing Strategies: Principles and Recent Progress of CUT&Tag